The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Progress report on new antiepileptic drugs: A summary of the Eigth Eilat Conference (EILAT VIII)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Gabapentin for acute and chronic pain
Wiffen, P. J., McQuay, H. J., Edwards, J., & Moore, R. A. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005452 · Cited by 237
RetractedGabapentin for acute and chronic pain
Wiffen, P. J., McQuay, H. J., Edwards, J., & Moore, R. A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005452.pub2 · Cited by 230
RetractedThe synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
Lynch, B. A., Lambeng, N., Nocka, K., Kensel-Hammes, P., Bajjalieh, S. M., Matagne, A., & Fuks, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308208101 · Cited by 1,610
A double‐blind, placebo‐controlled trial
Pinals, R. S., Kaplan, S. B., Lawson, J. G., & Hepburn, B. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291202 · Cited by 1,355
Morrow, J. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.074203 · Cited by 880
Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial
Dworkin, R. H., Corbin, A. E., Young, J. P., Sharma, U., LaMoreaux, L., Bockbrader, H., Garofalo, E. A., & Poole, R. M. (2003) · Neurology · doi:10.1212/01.wnl.0000055433.55136.55 · Cited by 768
Suppression of cortical spreading depression in migraine prophylaxis
Ayata, C., Jin, H., Kudo, C., Dalkara, T., & Moskowitz, M. A. (2006) · Annals of Neurology · doi:10.1002/ana.20778 · Cited by 570
Chiron, C., Marchand, M., Tran, A., Rey, E., d'Athis, P., Vincent, J., Dulac, O., & Pons, G. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03157-3 · Cited by 568
Diener, H.-C., Bussone, G., Oene, J. V., Lahaye, M., Schwalen, S., & Goadsby, P. (2007) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01326.x · Cited by 561
New onset geriatric epilepsy: A randomized study of gabapentin, lamotrigine, and carbamazepine
Rowan, A. J., Ramsay, R. E., Collins, J. F., Pryor, F., Boardman, K. D., Uthman, B. M., Spitz, M., Frederick, T., Towne, A., Carter, G. S., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000167384.68207.3e · Cited by 509
Silberstein, S. D., Lipton, R. B., Dodick, D. W., Freitag, F. G., Ramadan, N., Mathew, N., Brandes, J. L., Bigal, M., Saper, J., Ascher, S., et al. (2007) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00684.x · Cited by 497
Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortex
Fink, K., Dooley, D. J., Meder, W. P., Suman-Chauhan, N., Duffy, S., Clusmann, H., & Göthert, M. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00172-1 · Cited by 496
Efficacy and Safety of Oral Lacosamide as Adjunctive Therapy in Adults with Partial‐Onset Seizures
Ben‐Menachem, E., Biton, V., Jatuzis, D., Abou‐Khalil, B., Doty, P., & Rudd, G. D. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01188.x · Cited by 485
Severe persistent visual field constriction associated with vigabatrin: FIG 1
Eke, T., Talbot, J. F., & Lawden, M. C. (1997) · BMJ · doi:10.1136/bmj.314.7075.180 · Cited by 447
Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)
Crowder, K. M., Gunther, J. M., Jones, T. A., Hale, B. D., Zhang, H. Z., Peterson, M. R., Scheller, R. H., Chavkin, C., & Bajjalieh, S. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15268 · Cited by 415
Efficacy of Felbamate in Childhood Epileptic Encephalopathy (Lennox-Gastaut Syndrome)
(1993) · New England Journal of Medicine · doi:10.1056/nejm199301073280105 · Cited by 407
Lux, A. L., Edwards, S. W., Hancock, E., Johnson, A. L., Kennedy, C. R., Newton, R. W., O'Callaghan, F. J., Verity, C. M., & Osborne, J. P. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70199-x · Cited by 405
Risk of Stevens–Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics
Mockenhaupt, M., Messenheimer, J., Tennis, P., & Schlingmann, J. (2005) · Neurology · doi:10.1212/01.wnl.0000156354.20227.f0 · Cited by 399
Lux, A. L., Edwards, S. W., Hancock, E., Johnson, A. L., Kennedy, C. R., Newton, R. W., O'Callaghan, F. J., Verity, C. M., & Osborne, J. P. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17400-x · Cited by 374
Donevan, S. D., & Rogawski, M. A. (1993) · Neuron · doi:10.1016/0896-6273(93)90241-i · Cited by 358
The New Antiepileptic Drugs: A Systematic Review of Their Efficacy and Tolerability
Marson, A. G., Kadir, Z. A., Hutton, J. L., & Chadwick, D. W. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01251.x · Cited by 347
Diverse mechanisms of antiepileptic drugs in the development pipeline
Rogawski, M. A. (2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.02.004 · Cited by 340
Fehrenbacher, J. C., Taylor, C. P., & Vasko, M. R. (2003) · Pain · doi:10.1016/s0304-3959(03)00173-8 · Cited by 336
Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1
Borden, L. A., Dhar, T. G. M., Smith, K. E., Weinshank, R. L., Branchek, T. A., & Gluchowski, C. (1994) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(94)90089-2 · Cited by 334
Lauria-Horner, B. A., & Pohl, R. B. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.4.663 · Cited by 327
Pregabalin in Generalized Anxiety Disorder: A Placebo-Controlled Trial
Pande, A. C., Crockatt, J. G., Feltner, D. E., Janney, C. A., Smith, W. T., Weisler, R., Londborg, P. D., Bielski, R. J., Zimbroff, D. L., Davidson, J. R. T., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.533 · Cited by 314
Chiron, C., Dumas, C., Jambaqué, I., Mumford, J., & Dulac, O. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(96)01006-6 · Cited by 310
Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII)
Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Perucca, E., & Tomson, T. (2004) · Epilepsy Research · doi:10.1016/j.eplepsyres.2004.07.010 · Cited by 300
Self-citationCarter, R. B., Wood, P. L., Wieland, S., Hawkinson, J. E., Belelli, D., Lambert, J. J., White, H. S., Wolf, H. H., Mirsadeghi, S., Tahir, S. H., et al. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36511-5 · Cited by 269
Feltner, D. E., Crockatt, J. G., Dubovsky, S. J., Cohn, C. K., Shrivastava, R. K., Targum, S. D., Liu-Dumaw, M., Carter, C. M., & Pande, A. C. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000084032.22282.ff · Cited by 260
Nierenberg, A. A., Ostacher, M. J., Calabrese, J. R., Ketter, T. A., Marangell, L. B., Miklowitz, D. J., Miyahara, S., Bauer, M. S., Thase, M. E., Wisniewski, S. R., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.210 · Cited by 257
Pharmacokinetics of Pregabalin in Subjects with Various Degrees of Renal Function
Randinitis, E. J., Posvar, E. L., Alvey, C. W., Sedman, A. J., Cook, J. A., & Bockbrader, H. N. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003251119 · Cited by 257
Carter, R. B., Wood, P. L., Wieland, S., Hawkinson, J. E., Belelli, D., Lambert, J. J., White, H. S., Wolf, H. H., Mirsadeghi, S., Tahir, S. H., et al. (1997) · PubMed · Cited by 251
Rundfeldt, C., & Netzer, R. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00866-1 · Cited by 242
Guerreiro, M. M., Vigonius, U., Pohlmann, H., de Manreza, M. L. G., Fejerman, N., Antoniuk, S. A., & Moore, A. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(97)00025-9 · Cited by 241
D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures
Rostock, A., Tober, C., Rundfeldt, C., Bartsch, R., Engel, J., Polymeropoulos, E. E., Kutscher, B., Löscher, W., Hönack, D., White, H. S., et al. (1996) · Epilepsy Research · doi:10.1016/0920-1211(95)00101-8 · Cited by 240
Löscher, W., & Schmidt, D. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00607.x · Cited by 239
Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures
French, J. A., Kugler, A. R., Robbins, J. L., Knapp, L. E., & Garofalo, E. A. (2003) · Neurology · doi:10.1212/01.wnl.0000068024.20285.65 · Cited by 239
The relationship between poor medication compliance and seizures
Cramer, J. A., Glassman, M., & Rienzi, V. (2002) · Epilepsy & Behavior · doi:10.1016/s1525-5050(02)00037-9 · Cited by 228
Kenda, B. M., Matagne, A. C., Talaga, P. E., Pasau, P. M., Differding, E., Lallemand, B. I., Frycia, A. M., Moureau, F. G., Klitgaard, H. V., Gillard, M. R., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030913e · Cited by 226
Clinical Pharmacokinetics of Oxcarbazepine
May, T. W., Korn-Merker, E., & Rambeck, B. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342120-00002 · Cited by 224
Dooley, D. J., Donovan, C. M., & Pugsley, T. A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39009-3 · Cited by 217
Blackburn-Munro, G., & Jensen, B. S. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02924-2 · Cited by 208
Zangara, A. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00111-4 · Cited by 208
Best Practice Guidelines for the Management of Women with Epilepsy
Crawford, P. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00323.x · Cited by 203
Lamotrigine inhibits Ca2+ currents in cortical neurons: functional implications
Stefani, A., Spadoni, F., Siniscalchi, A., & Bernardi, G. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00265-8 · Cited by 200
Ramael, S., Daoust, A., Otoul, C., Toublanc, N., Troenaru, M., Lu, Z. (., & Stockis, A. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00586.x · Cited by 192
Schmidt, D., & Elger, C. E. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2004.07.004 · Cited by 190
Interactions Between Antiepileptic Drugs and Hormonal Contraception
Crawford, P. (2002) · CNS Drugs · doi:10.2165/00023210-200216040-00005 · Cited by 189
Fink-Jensen, A., Suzdak, P. D., Swedberg, M. D. B., Judge, M. E., Hansen, L., & Nielsen, P. G. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90748-s · Cited by 185
Sidhu, J., Job, S., Singh, S., & Philipson, R. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02539.x · Cited by 185
Dierking, G., Duedahl, T. H., Rasmussen, M. L., Fomsgaard, J. S., MØiniche, S., RØmsing, J., & Dahl, J. B. (2004) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.0001-5172.2004.0329.x · Cited by 185
Maneuf, Y. P., Hughes, J., & McKnight, A. T. (2001) · Pain · doi:10.1016/s0304-3959(01)00316-5 · Cited by 184
CHANG, K., SAXENA, K., & HOWE, M. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000194566.86160.a3 · Cited by 182
Vagus nerve stimulation for 1 year in 269 patients on unchanged antiepileptic drugs
Labar, D. (2004) · Seizure · doi:10.1016/j.seizure.2003.09.009 · Cited by 182
Dooley, D. J., Donovan, C. M., Meder, W. P., & Whetzel, S. Z. (2002) · Synapse · doi:10.1002/syn.10094 · Cited by 180
Kaminski, R. M., Livingood, M. R., & Rogawski, M. A. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.04504.x · Cited by 179
Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV)
Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Loiseau, P., & Perucca, E. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(98)00108-9 · Cited by 179
Self-citationTopiramate for Migraine Prevention in Children: A Randomized, Double‐Blind, Placebo‐Controlled Trial
Winner, P., Pearlman, E. M., Linder, S. L., Jordan, D. M., Fisher, A. C., Hulihan, J., & for the Topiramate Pediatric Migraine Study Investigators (2005) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2005.00262.x · Cited by 177
Differential effects of antiepileptic drugs on sexual function and hormones in men with epilepsy
Herzog, A. G., Drislane, F. W., Schomer, D. L., Pennell, P. B., Bromfield, E. B., Dworetzky, B. A., Farina, E. L., & Frye, C. A. (2005) · Neurology · doi:10.1212/01.wnl.0000178988.78039.40 · Cited by 173
Adjunctive therapy with oxcarbazepine in children with partial seizures
Glauser, T. A., Nigro, M., Sachdeo, R., Pasteris, L. A., Weinstein, S., Abou-Khalil, B., Frank, L. M., Grinspan, A., Guarino, T., Bettis, D., et al. (2000) · Neurology · doi:10.1212/wnl.54.12.2237 · Cited by 173
Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI)
Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Loiseau, P., & Perucca, E. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00106-7 · Cited by 172
Self-citationEthinyl Estradiol, Not Progestogens, Reduces Lamotrigine Serum Concentrations
Reimers, A., Helde, G., & Brodtkorb, E. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.10105.x · Cited by 165
Nickel, C., Tritt, K., Muehlbacher, M., Pedrosa Gil, F., Mitterlehner, F. O., Kaplan, P., Lahmann, C., Leiberich, P. K., Krawczyk, J., Kettler, C., et al. (2005) · International Journal of Eating Disorders · doi:10.1002/eat.20202 · Cited by 162
Mazarati, A. M., & Wasterlain, C. G. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00238-4 · Cited by 160
Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers
Meador, K. J., Loring, D. W., Vahle, V. J., Ray, P. G., Werz, M. A., Fessler, A. J., Ogrocki, P. K., Schoenberg, M. R., Miller, J. M., & Kustra, R. P. (2005) · Neurology · doi:10.1212/01.wnl.0000165994.46777.be · Cited by 152
Cundy, K. C., Branch, R., Chernov-Rogan, T., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.067934 · Cited by 152
Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)
Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Loiseau, P., & Perucca, E. (2001) · Epilepsy Research · doi:10.1016/s0920-1211(00)00171-6 · Cited by 152
Self-citationQuilichini, P., Chiron, C., Ben‐Ari, Y., & GOZLAN, H. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00497.x · Cited by 150
Lees, G. J. (2000) · Drugs · doi:10.2165/00003495-200059010-00004 · Cited by 149
Backman, J. T., Olkkola, K. T., Ojala, M., Laaksovirta, H., & Neuvonen, P. J. (1996) · Epilepsia · doi:10.1111/j.1528-1157.1996.tb00021.x · Cited by 149
Gillard, M., Chatelain, P., & Fuks, B. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.02.022 · Cited by 148
Stiripentol: Efficacy and Tolerability in Children with Epilepsy
Perez, J., Chiron, C., Musial, C., Rey, E., Blehaut, H., D'Athis, P., Vincent, J., & Dulac, O. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb02048.x · Cited by 148
Reddy, D. S., & Rogawski, M. A. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39026-3 · Cited by 148
Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus
Yaffe, K. S., & Lowenstein, D. H. (1993) · Neurology · doi:10.1212/wnl.43.5.895 · Cited by 147
Yamaguchi, S., Donevan, S. D., & Rogawski, M. A. (1993) · Epilepsy Research · doi:10.1016/0920-1211(93)90054-b · Cited by 146
Inter- and intra-subject variability in gabapentin absorption and absolute bioavailability
Gidal, B. E., Radulovic, L. L., Kruger, S., Rutecki, P. A., Pitterle, M. E., & Bockbrader, H. N. (2000) · Epilepsy Research · doi:10.1016/s0920-1211(00)00117-0 · Cited by 145
Topiramate in the Long-Term Treatment of Binge-Eating Disorder Associated with Obesity
McElroy, S. L., Shapira, N. A., Arnold, L. M., Keck, P. E., Rosenthal, N. R., Wu, S., Capece, J. A., Fazzio, L., & Hudson, J. I. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1104 · Cited by 144
Öhman, I., Vitols, S., & Tomson, T. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00251.x · Cited by 141
Self-citationHallböök, T., Lundgren, J., Stjernqvist, K., Gösta Blennow, A., Strömblad, L.-G., & Rosén, I. (2005) · Seizure · doi:10.1016/j.seizure.2005.08.007 · Cited by 140
D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures
Tober, C., Rostock, A., Rundfeldt, C., & Bartsch, R. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00073-8 · Cited by 139
Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial
Kerrigan, J., Shields, W. D., Nelson, T. Y., Bluestone, D. L., Dodson, W. E., Bourgeois, B. F. D., Pellock, J. M., Morton, L. D., & Monaghan, E. P. (2000) · Epilepsy Research · doi:10.1016/s0920-1211(00)00170-4 · Cited by 139
Topiramate inhibits cortical spreading depression in rat and cat: impact in migraine aura
Akerman, S., & Goadsby, P. J. (2005) · Neuroreport · doi:10.1097/01.wnr.0000175250.33159.a9 · Cited by 138
Margineanu, D. G., & Klitgaard, H. (2000) · Pharmacological Research · doi:10.1006/phrs.2000.0689 · Cited by 135
Brodie, M. J., Wilson, E. A., WESCHE, D. L., Alvey, C. W., Randinitis, E. J., Posvar, E. L., Hounslow, N. J., Bron, N. J., Gibson, G. L., & Bockbrader, H. N. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.19204.x · Cited by 135
IN VITRO AND IN VIVO INHIBITORY EFFECT OF STIRIPENTOL ON CLOBAZAM METABOLISM
Giraud, C., Tréluyer, J., Rey, E., Chiron, C., Vincent, J., Pons, G., & Tran, A. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.007237 · Cited by 134
The Mechanism of Neuroprotection by Topiramate in an Animal Model of Epilepsy
Kudin, A. P., Dębska–Vielhaber, G., Vielhaber, S., Elger, C. E., & Kunz, W. S. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.13504.x · Cited by 132
Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassium currents
Danielsson, B. R. G., Lansdell, K., Patmore, L., & Tomson, T. (2004) · Epilepsy Research · doi:10.1016/j.eplepsyres.2004.10.002 · Cited by 130
Self-citationPregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity
Field, M. J., Oles, R. J., & Singh, L. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703794 · Cited by 129
Amar, A. P., Apuzzo, M. L. J., & Liu, C. Y. (2004) · Neurosurgery · doi:10.1227/01.neu.0000141073.08427.76 · Cited by 129
Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers
Salinsky, M., Storzbach, D. M., Spencer, D. C., Oken, B., Landry, T., & Dodrill, C. B. (2005) · Neurology · doi:10.1212/01.wnl.0000152877.08088.87 · Cited by 129
Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures
Biton, V., Sackellares, J. C., Vuong, A., Hammer, A. E., Barrett, P. S., & Messenheimer, J. A. (2005) · Neurology · doi:10.1212/01.wnl.0000187118.19221.e4 · Cited by 128
Loew, T. H., Nickel, M. K., Muehlbacher, M., Kaplan, P., Nickel, C., Kettler, C., Fartacek, R., Lahmann, C., Buschmann, W., Tritt, K., et al. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000195113.61291.48 · Cited by 127
Pressler, R., Robinson, R. O., Wilson, G. A., & Binnie, C. D. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.08.084 · Cited by 127
Initial Human Experience with Ganaxolone, a Neuroactive Steroid with Antiepileptic Activity
Monaghan, E. P., Navalta, L. A., Shum, L., Ashbrook, D. W., & Lee, D. A. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01486.x · Cited by 124
Pollack, M. H., Roy‐Byrne, P., Ameringen, M. V., Snyder, H., Brown, C. E., Ondrasik, J., & Rickels, K. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1109 · Cited by 122
New antiepileptic drugs that are second generation to existing antiepileptic drugs
Bialer, M. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.6.637 · Cited by 122
Self-citationVed, H. S., Koenig, M. L., Dave, J. R., & Doctor, B. P. (1997) · Neuroreport · doi:10.1097/00001756-199703030-00029 · Cited by 115
Ramael, S., Smedt, F. D., Toublanc, N., Otoul, C., Boulanger, P., Riethuisen, J., & Stockis, A. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.05.004 · Cited by 113
Johnson, B. A., Ait‐Daoud, N., Akhtar, F. Z., & Javors, M. A. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.14.1600 · Cited by 112
Effect of oral gabapentin on postoperative epidural analgesia
Turan, A., Kaya, G., Karamanlıoğlu, B., Pamukçu, Z., & Apfel, C. C. (2005) · British Journal of Anaesthesia · doi:10.1093/bja/aei294 · Cited by 112
Tran, A., Rey, E., Pons, G., Rousseau, M., d’Athis, P., Olivé, G., MATHER, G. G., Bishop, F. E., Wurden, C. J., Labroo, R. B., et al. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90044-8 · Cited by 110
Self-citationA single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster
Berry, J. D., & Petersen, K. L. (2005) · Neurology · doi:10.1212/01.wnl.0000168259.94991.8a · Cited by 110
Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase
Shank, R. P., Doose, D. R., Streeter, A. J., et al. (2005) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.01.001 · Cited by 109
Visual Field Defects with Vigabatrin
inen, R. K. L., & Nousiainen, I. (2001) · CNS Drugs · doi:10.2165/00023210-200115030-00005 · Cited by 108
Kremer, I., Vass, Á., Gorelik, I., Bar, G., Blanaru, M., Javitt, D. C., & Heresco‐Levy, U. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.029 · Cited by 107
Effect of vagus nerve stimulation on adults with pharmacoresistant generalized epilepsy syndromes
Holmes, M., Silbergeld, D. L., Drouhard, D., Wilensky, A. J., & Ojemann, L. M. (2003) · Seizure · doi:10.1016/j.seizure.2003.09.002 · Cited by 107
Laxer, K. D., Blum, D. E., Abou‐Khalil, B. W., Morrell, M. J., Lee, D. A., Data, J. L., Monaghan, E. P., & the Ganaxolone Presurgical Study Group (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00324.x · Cited by 106
Molecular Mechanism of AMPA Receptor Noncompetitive Antagonism
Balannik, V., Menniti, F. S., Paternain, A. V., Lerma, J., & Stern-Bach, Y. (2005) · Neuron · doi:10.1016/j.neuron.2005.09.024 · Cited by 102
Almeida, L., Falcão, A. C., Maia, J., Mazur, D., Gellert, M., & Soares-da-Silva, P. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005279364 · Cited by 102
Stiripentol kinetics in epilepsy: Nonlinearity and interactions
Levy, R. H., Loiseau, P., Guyot, M., Bléhaut, H., Tor, J., & Moreland, T. A. (1984) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1984.237 · Cited by 99
Self-citationTopiramate Add-On in Treatment-Resistant Schizophrenia
Tiihonen, J., Halonen, P. M., Wahlbeck, K., Repo‐Tiihonen, E., Hyvärinen, S., Eronen, M., Putkonen, H., Takala, P., Mehtonen, O. ‐., Puck, M., et al. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0808 · Cited by 98
Vagus nerve stimulation for refractory idiopathic generalised epilepsy
NG, M., & Devinsky, O. (2003) · Seizure · doi:10.1016/s1059-1311(03)00147-x · Cited by 98
Changes in the Disposition of Oxcarbazepine and Its Metabolites during Pregnancy and the Puerperium
Mazzucchelli, I., Onat, F., Özkara, Ç., Ataklı, D., Specchio, L. M., Neve, A. L., Gatti, G., & Perucca, E. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00459.x · Cited by 97
Self-citationKuzmiski, J. B., Barr, W., Zamponi, G. W., & MacVicar, B. A. (2005) · Epilepsia · doi:10.1111/j.0013-9580.2005.35304.x · Cited by 97
Topiramate in Treatment of Patients With Chronic Low Back Pain
Muehlbacher, M., Nickel, M. K., Kettler, C., Tritt, K., Lahmann, C., Leiberich, P. K., Nickel, C., Krawczyk, J., Mitterlehner, F. O., Rother, W. K., et al. (2006) · Clinical Journal of Pain · doi:10.1097/.ajp.0000192516.58578.a4 · Cited by 96
Activity profile of pregabalin in rodent models of epilepsy and ataxia
Vartanian, M. G., Radulovic, L. L., Kinsora, J. J., et al. (2005) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.11.001 · Cited by 95
Winhusen, T. M., Somoza, E. C., Harrer, J. M., Mezinskis, J. P., Montgomery, M. A., Goldsmith, R. J., Coleman, F. S., Bloch, D. A., Leiderman, D. B., Singal, B. M., et al. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.00992.x · Cited by 95
Ängehagen, M., Rönnbäck, L., Hansson, E., & Ben‐Menachem, E. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03259.x · Cited by 93
Metabolism of Retigabine (D-23129), a Novel Anticonvulsant
Hempel, R., Schupke, H., McNeilly, P. J., Heinecke, K., Kronbach, C., Grunwald, C., Zimmermann, G., Griesinger, C., Engel, J., & Kronbach, T. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15258-0 · Cited by 90
Carbamazepine-10,11-Epoxide in Therapeutic Drug Monitoring
Potter, J. M., & Donnelly, A. (1998) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199812000-00012 · Cited by 89
Tiagabine enhances slow wave sleep and sleep maintenance in primary insomnia
WALSH, J., Zammit, G. K., Schweitzer, P. K., Ondrasik, J., & Roth, T. G. (2005) · Sleep Medicine · doi:10.1016/j.sleep.2005.05.004 · Cited by 88
Multiple‐Dose, Linear, Dose‐Proportional Pharmacokinetics of Retigabine in Healthy Volunteers
Ferron‐Brady, G., Paul, J., Fruncillo, R. J., Richards, L. S., Knebel, N. G., Getsy, J. A., & Troy, S. M. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/00912700222011210 · Cited by 86
Losing Neurons: Selective Vulnerability and Mesial Temporal Sclerosis
Lewis, D. V. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00306.x · Cited by 82
Connor, K. M., Davidson, J. R. T., Weisler, R. H., Zhang, W., & Abraham, K. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0265-3 · Cited by 82
Vagus nerve stimulation therapy: 5-year or greater outcome at a university-based epilepsy center
Spanaki, M. V., Allen, L., Mueller, W. M., & Morris, G. L. (2004) · Seizure · doi:10.1016/j.seizure.2004.01.009 · Cited by 76
Roth, T. G., Wright, K. P., & Walsh, J. K. (2006) · SLEEP · doi:10.1093/sleep/29.3.335 · Cited by 74
Beneficial effects on sleep of vagus nerve stimulation in children with therapy resistant epilepsy
Hallböök, T., Lundgren, J., Köhler, S., Gösta Blennow, A., Strömblad, L.-G., & Rosén, I. (2005) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2005.08.004 · Cited by 70
Visual field constriction and electrophysiological changes associated with vigabatrin
Besch, D., Kurtenbach, A., Apfelstedt-Sylla, E., Sadowski, B., Dennig, D., Asenbauer, C., Zrenner, E., & Schiefer, U. (2002) · Documenta Ophthalmologica · doi:10.1023/a:1014644307518 · Cited by 69
Isoherranen, N., Yagen, B., & Bialer, M. (2003) · Current Opinion in Neurology · doi:10.1097/01.wco.0000063774.81810.30 · Cited by 69
Self-citationThe absorption of gabapentin following high dose escalation
Berry, D. J., Beran, R. G., PLUNKEFT, M. J., Clarke, L. A., & Hung, W. T. (2002) · Seizure · doi:10.1016/s1059131102001425 · Cited by 69
Newer treatment studies for bipolar depression
Gao, K., & Calabrese, J. R. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00250.x · Cited by 67
Zhou, J., Zhang, H.-Y., & Tang, X.-C. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02265-0 · Cited by 66
Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers
Sofuoglu, M., Poling, J. C., Mouratidis, M., & Kosten, T. R. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0296-9 · Cited by 66
A new type of anticonvulsant, stiripentol. Pharmacological profile and neurochemical study.
Poisson, M., Huguet, F., Savattier, A., BAKRI‐LOGEAIS, F., & Narcisse, G. (1984) · PubMed · Cited by 65
Pellock, J. M., Smith, M. C., Cloyd, J. C., Uthman, B., & Wilder, B. J. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2004.01.009 · Cited by 64
Effects of lamotrigine in patients with bipolar disorder and alcohol dependence
Rubio, G., López‐Muñoz, F., & Alamo, C. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00292.x · Cited by 64
Dutta, S., Zhang, Y., Selness, D. S., Lee, L. L., Williams, L. A., & Sommerville, K. W. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00007-4 · Cited by 63
Huperzine A attenuates apoptosis and mitochondria‐dependent caspase‐3 in rat cortical neurons
Zhou, J., & Tang, X. C. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03107-1 · Cited by 61
Walsh, J. K., Perlis, M. L., Rosenthal, M. H., Krystal, A. D., Jiang, J., & Roth, T. G. (2006) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.26433 · Cited by 59
Pharmacokinetic interaction between retigabine and lamotrigine in healthy subjects
Hermann, R., Knebel, N. G., Niebch, G., Richards, L. S., Borlak, J., & Locher, M. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0558-6 · Cited by 58
Huf, R., Mamelak, A. N., & Kneedy-Cayem, K. (2005) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2005.01.009 · Cited by 58
Ye, J. W., Cai, J. X., Wang, L. M., & Tang, X. C. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38024-3 · Cited by 58
Lamotrigine for bipolar disorder and comorbid cocaine dependence: A replication and extension study
Brown, E. S., Perantie, D. C., Dhanani, N., Beard, L., Orsulak, P. J., & Rush, A. J. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.02.001 · Cited by 57
Rogawski, M. A., Kurzman, P. S., Yamaguchi, S.-I., & Li, H. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00112-x · Cited by 56
Topiramate Improves Health‐Related Quality of Life When Used to Prevent Migraine
Diamond, M. L., Dahlöf, C. G. H., Papadopoulos, G., Neto, W., & S‐C, W. (2005) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2005.05183.x · Cited by 56
Topiramate for Migraine Prevention
Wenzel, R. G., Schwarz, K. A., & Vellurattil, R. P. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.3.375 · Cited by 55
Widespread Upregulation of Drug‐resistance Proteins in Fatal Human Status Epilepticus
Sisodiya, S. M., & Thom, M. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.42802.x · Cited by 54
Inhibitory effect of stiripentol on carbamazepine and saquinavir metabolism in human
Cazali, N., Tran, A., Tréluyer, J., Rey, E., d’Athis, P., Vincent, J., & Pons, G. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2003.01919.x · Cited by 53
Lamotrigine versus carbamazepine monotherapy for epilepsy
Gamble, C. L., Williamson, P. R., & Marson, A. G. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001031.pub2 · Cited by 52
SPD 502: A Water-Soluble and In Vivo Long-Lasting Ampa Antagonist with Neuroprotective Activity
Nielsen, E. Ø., Varming, T., Mathiesen, C., Jensen, L. H., Møller, A., Gouliaev, A. H., Wätjen, F., & Drejer, J. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38297-7 · Cited by 52
Pharmacokinetics of tablet huperzine A in six volunteers.
Qian, B., Wang, M., Zhou, Z., et al. (1995) · PubMed · Cited by 52
Effect of Food on the Pharmacokinetic Profile of Eslicarbazepine Acetate (BIA 2-093)
Maia, J., Vaz‐da‐Silva, M., Almeida, L., o, A. F., Silveira, P., es, S. G., Graziela, P., & Soares-da-Silva, P. (2005) · Drugs in R&D · doi:10.2165/00126839-200506040-00002 · Cited by 50
Kapetanović, I. M., Torchin, C. D., Thompson, C. D., Miller, T. A., McNeilly, P. J., Macdonald, T. L., Kupferberg, H. J., Perhach, J. L., Sofia, R. D., & Strong, J. M. (1998) · PubMed · Cited by 49
Self-citationNeurosteroids: Endogenous Modulators of Seizure Susceptibility
Rogawski, M. A., & Reddy, D. S. (2004) · Cited by 49
Brown, J. S., Papadopoulos, G., Neumann, P. J., Friedman, M., Miller, J. D., & Menzin, J. (2005) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2005.05182.x · Cited by 48
Ferron‐Brady, G., Patat, A. A., Parks, V., Rolan, P. E., & Troy, S. M. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01825.x · Cited by 47
Kasper, C., Pickering, D. S., Mirza, O., Olsen, L., Kristensen, A. S., Greenwood, J. R., Liljefors, T., Schousboe, A., Wätjen, F., Gajhede, M., et al. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.01.024 · Cited by 44
Zoidis, G., Papanastasiou, I. P., Dotsikas, Y., Sandoval, A., dos Santos, R. G., Papadopoulou‐Daifoti, Z., Vamvakidès, A., Kolocouris, N., & Felix, R. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.02.030 · Cited by 44
Hirai, T., Okuma, C., Harada, C., Mio, M., Ohtsu, H., Watanabe, T., & Kamei, C. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.19303.x · Cited by 42
Sommerville, K. W., Dutta, S., Biton, V., Zhang, Y., Cloyd, J. C., & Uthman, B. M. (2003) · Clinical Drug Investigation · doi:10.2165/00044011-200323100-00005 · Cited by 40
Smith, M. C. F., Centorrino, F., Welge, J. A., & Collins, M. A. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2004.07.007 · Cited by 39
Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers
Sofuoglu, M., Mouratidis, M., Yoo, S., Culligan, K., & Kosten, T. R. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0010-y · Cited by 39
Editorial II: Gabapentin: a new drug for postoperative pain?
Rowbotham, D. J. (2006) · British Journal of Anaesthesia · doi:10.1093/bja/aei318 · Cited by 38
Second generation cholinesterase inhibitors: Effect of (L)‐huperzine‐A on cortical biogenic amines
Zhu, X. ‐., & Giacobini, E. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490410613 · Cited by 38
Christensen, J. K., Varming, T., Ahring, P. K., Jørgensen, T. D., & Nielsen, E. Ø. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.062794 · Cited by 37
Jakus, R., Gráf, M., Andó, R. D., Balogh, B., Gacsályi, I., Lévay, G. I., Kántor, S., & Bagdy, G. (2004) · Brain Research · doi:10.1016/j.brainres.2004.01.087 · Cited by 37
Determinants of Ictal Epileptiform Patterns in the Hippocampal Slice
Rutecki, P. A., Sayın, Ü., Yang, Y., & Hadar, E. J. (2002) · Epilepsia · doi:10.1046/j.1528-1157.43.s.5.34.x · Cited by 36
(2004) · CRC Press eBooks · doi:10.3109/9780203021934 · Cited by 34
Dutta, S., Reed, R. C., & Cavanaugh, J. H. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004266782 · Cited by 34
Anticonvulsant and antiepileptogenic effects of fluorofelbamate in experimental status epilepticus
Mazarati, A. M., Sofia, R. D., & Wasterlain, C. G. (2002) · Seizure · doi:10.1053/seiz.2002.0677 · Cited by 31
Effect of stiripentol on carbamazepine plasma concentration and metabolism in epileptic children
Tran, A., Vauzelle-Kervroedan, F., Rey, E., Pons, G., d'Athis, P., Chiron, C., Dulac, O., Renard, F., & Olivé, G. (1996) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050147 · Cited by 30
Secondary prevention after ischemic stroke: Evolution over time in practice
Girot, M., Mackowiak‐Cordoliani, M., Deplanque, D., H�non, H., Lucas, C., & Leys, D. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0591-8 · Cited by 30
Hemophagocytic syndrome associated with antiepileptic drug
Yang, Y.-C., Jou, S., Chang, Y.-H., Liang, J., & Lee, W. (2004) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2003.12.012 · Cited by 29
Protective Effect of Stiripentol on Acetaminophen-Induced Hepatotoxicity in Rat
Tran, A., Tréluyer, J., Rey, E., Barbet, P., Ferracci, G., d’Athis, P., Vincent, J., & Pons, G. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2000.9091 · Cited by 28
Longitudinal changes in photopic OPs occurring with vigabatrin treatment
Morong, S., Westall, C. A., Nobile, R., Buncic, J. R., Logan, W. J., Panton, C. M., & Abdolell, M. (2003) · Documenta Ophthalmologica · doi:10.1023/b:doop.0000005338.51554.e3 · Cited by 25
Divalproex-ER pharmacokinetics in older children and adolescents
Dutta, S., Zhang, Y., Conway, J. M., Sallee, F. R., Biton, V., Reed, M. D., & Kearns, G. L. (2004) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2003.12.006 · Cited by 25
Inghilleri, M., Gilio, F., Conte, A., Frasca, V., Bettolo, C. M., Iacovelli, E., Gregori, B., Prencipe, M., & Berardelli, A. (2006) · Experimental Brain Research · doi:10.1007/s00221-006-0506-7 · Cited by 25
Brivaracetam Is A Potent Anticonvulsant In Experimental Status Epilepticus: 2.381
Wasterlain, C. G., Suchomelová, L., Matagne, A., Klitgaard, H., Mazarati, A. M., Shinmei, S. S., & Baldwin, R. A. (2005) · Epilepsia · Cited by 25
An Open-label Study of Tiagabine as Augmentation Therapy for Anxiety
Schwartz, T. L., Azhar, N., Husain, J., Nihalani, N. D., Simionescu, M., Coovert, D., Jindal, S., & Tirmazi, S. (2005) · Annals of Clinical Psychiatry · doi:10.1080/10401230591002138 · Cited by 23
Zhang, Y., Zhao, X., Chen, X.-Q., Wang, Y., Yang, H., & Hu, G. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02565-4 · Cited by 22
Werz, M. A., Schoenberg, M. R., Meador, K. J., Loring, D. W., Ray, P. G., Kaul-Gupta, R., & Ogrocki, P. K. (2005) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2005.09.003 · Cited by 20
Eslicarbazepine Acetate (BIA 2-093)
Ribeiro, C., Nunes, T., o, A. F., Neta, C., Lima, R., Tavares, S., Almeida, L., Macedo, T., & Soares-da-Silva, P. (2005) · Drugs in R&D · doi:10.2165/00126839-200506050-00001 · Cited by 19
Extended Release Formulations of Anticonvulsant Medications
Collins, R. J., & Garnett, W. R. (2000) · CNS Drugs · doi:10.2165/00023210-200014030-00003 · Cited by 18
Dutta, S., Reed, R. C., & OʼDea, R. F. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g617 · Cited by 18
Low-dose tiagabine effectiveness in anxiety disorders.
Schaller, J. L., Thomas, J. J., & Rawlings, D. (2004) · PubMed · Cited by 17
Ha, E., Yim, S. V., Jung, K. H., Yoon, S. H., Zheng, L. T., Kim, M., Hong, S.-C., Choe, B., Baik, H. H., Chung, J., et al. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500366 · Cited by 17
McCabe, P. H., Michel, N. C., McNew, C. D., & Lehman, E. B. (2006) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2006.02.006 · Cited by 16
Effect of stiripentol dose on phenytoin-induced teratogenesis in a mouse model
Finnell, R. H., Bennett, G. D., Mather, G. G., Wlodarczyk, B. J., Bajpai, M., & Levy, R. H. (1999) · Reproductive Toxicology · doi:10.1016/s0890-6238(98)00067-7 · Cited by 16
Self-citationAdverse reactions of Topiramate and Lamotrigine in children
Shechter, T., Shorer, Z., Kramer, U., Lerman‐Sagie, T., Ronen, E., Rotem, R., & Gorodischer, R. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1041 · Cited by 16
Reed, R. C., Dutta, S., Cavanaugh, J. H., Locke, C. S., & Granneman, G. R. (2006) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2005.12.004 · Cited by 14
Nefritis intersticial aguda y lamotrigina: Report of one case
Gustavo Mönckeberg, F., Antonio Vukusich, C., Gonzalo Valls, G., & Rosenberg, H. (2004) · Revista médica de Chile · doi:10.4067/s0034-98872004000600011 · Cited by 12
Reed, R. C., & Dutta, S. (2006) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000211814.12311.3f · Cited by 12
Cited by
New avenues for anti-epileptic drug discovery and development
Löscher, W., Klitgaard, H., Twyman, R. E., & Schmidt, D. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4126 · Cited by 675
(2010) · Progress in Brain Research · doi:10.1016/b978-0-444-53630-3.00008-7 · Cited by 584
Key factors in the discovery and development of new antiepileptic drugs
Bialer, M., & White, H. S. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2997 · Cited by 542
Self-citationEfficacy and Safety of Oral Lacosamide as Adjunctive Therapy in Adults with Partial‐Onset Seizures
Ben‐Menachem, E., Biton, V., Jatuzis, D., Abou‐Khalil, B., Doty, P., & Rudd, G. D. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01188.x · Cited by 485
Adibhatla, R. M., & Hatcher, J. F. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2668 · Cited by 480
Metadata
- Authors
- Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Perucca, E., & Tomson, T.
- Venue
- Epilepsy Research
- Publisher
- Elsevier BV
- Published
- 2007-01
- Volume
- 73
- Issue
- 1
- Pages
- 1-52
- ISSN
- 0920-1211 (ISSN-L)
- OpenAlex
- W2025797846
- Cited by
- 477
- References
- 194
- FWCI
- 26.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.